International Clinical Trial: A single-center, randomized, open-label, two-period, two-sequence crossover clinical study to evaluate the effect of food on the pharmacokinetic characteristics of CMS-D001 tablets in healthy participants

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123119) titled 'A single-center, randomized, open-label, two-period, two-sequence crossover clinical study to evaluate the effect of food on the pharmacokinetic characteristics of CMS-D001 tablets in healthy participants' on April 22.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University

Condition: Pharmacokinetics of CMS-D001 tablets

Intervention: A Group (Fasting - Postprandial):CMS-D001 tablet 100 mg, single oral administration. Fasting administration in the first cycle, postprandial (high-fat meal) administration in the second cycle.

Recruitme...